Resolution Therapeutics

Resolution Therapeutics, located in Edinburgh, UK, focuses on developing macrophages to repair organ damage, including treatments for end-stage chronic liver disease. Its related investigational drug has now entered Phase II clinical trials. Resolution was founded based on 10 years of research from the Forbes Lab at the University of Edinburgh's Centre for Regenerative Medicine. The first project is an engineered macrophage for treating patients with compensated cirrhosis.